BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26438681)

  • 1. A case of donepezil-related torsades de pointes.
    Kitt J; Irons R; Al-Obaidi M; Missouris C
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26438681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsades de Pointes with QT prolongation related to donepezil use.
    Takaya T; Okamoto M; Yodoi K; Hata K; Kijima Y; Nakajima H; Nishikawa Y; Kita T; Ito M; Seo T; Kawashima S
    J Cardiol; 2009 Dec; 54(3):507-11. PubMed ID: 19944332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesson of the month 1: Prolonged QT syndrome due to donepezil: a reversible cause of falls?
    Jackson EG; Stowe S
    Clin Med (Lond); 2019 Jan; 19(1):80-81. PubMed ID: 30651253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angle-closure glaucoma after discontinuing donepezil hydrochloride (Aricept).
    Enzenauer RW; Bowers PJ
    J Gerontol A Biol Sci Med Sci; 2005 Aug; 60(8):1083. PubMed ID: 16127117
    [No Abstract]   [Full Text] [Related]  

  • 5. Mania associated with donepezil.
    Benazzi F
    J Psychiatry Neurosci; 1999 Nov; 24(5):468-9. PubMed ID: 10586539
    [No Abstract]   [Full Text] [Related]  

  • 6. Donepezil-induced adverse side effects of cardiac rhythm: 2 cases report of atrioventricular block and Torsade de Pointes.
    Tanaka A; Koga S; Hiramatsu Y
    Intern Med; 2009; 48(14):1219-23. PubMed ID: 19602789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deterioration in donepezil-induced PR prolongation after a coadministration of memantine in a patient with Alzheimer's disease.
    Igeta H; Suzuki Y; Motegi T; Sasaki A; Yokoyama Y; Someya T
    Gen Hosp Psychiatry; 2013; 35(6):680.e9-10. PubMed ID: 23731891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac safety of donepezil in elderly patients with Alzheimer disease.
    Isik AT; Yildiz GB; Bozoglu E; Yay A; Aydemir E
    Intern Med; 2012; 51(6):575-8. PubMed ID: 22449664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Shortening of donepezil-induced QTc prolongation with a change in the interacting drug, after electrocardiograph monitoring by community pharmacists: a case report].
    Shinozaki K
    Yakugaku Zasshi; 2012; 132(2):237-41. PubMed ID: 22293706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nightmares in patients with Alzheimer's disease caused by donepezil. Therapeutic effect depends on the time of intake].
    Singer M; Romero B; Koenig E; Förstl H; Brunner H
    Nervenarzt; 2005 Sep; 76(9):1127-8, 1129. PubMed ID: 15630600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapyramidal side-effect due to drug combination of risperidone and donepezil.
    Liu HC; Lin SK; Sung SM
    Psychiatry Clin Neurosci; 2002 Aug; 56(4):479. PubMed ID: 12109969
    [No Abstract]   [Full Text] [Related]  

  • 12. How the FDA forgot the evidence: the case of donepezil 23 mg.
    Schwartz LM; Woloshin S
    BMJ; 2012 Mar; 344():e1086. PubMed ID: 22442352
    [No Abstract]   [Full Text] [Related]  

  • 13. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain with donepezil.
    Kuloor CB; Puranik A
    Age Ageing; 2006 Nov; 35(6):639-40. PubMed ID: 16820527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.
    Homma A; Atarashi H; Kubota N; Nakai K; Takase T
    J Alzheimers Dis; 2016 Mar; 52(1):345-57. PubMed ID: 26967222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.
    Nozawa M; Ichimiya Y; Nozawa E; Utumi Y; Sugiyama H; Murayama N; Iseki E; Arai H
    Psychogeriatrics; 2009 Jun; 9(2):50-5. PubMed ID: 19604325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil and athetosis in an elderly patient with Alzheimer's disease.
    Tanaka M; Yokode M; Kita T; Matsubayashi K
    J Am Geriatr Soc; 2003 Jun; 51(6):889-90. PubMed ID: 12757588
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study.
    Boada-Rovira M; Brodaty H; Cras P; Baloyannis S; Emre M; Zhang R; Bahra R;
    Drugs Aging; 2004; 21(1):43-53. PubMed ID: 14715043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term use of donepezil and QTc prolongation.
    Kho J; Ioannou A; Mandal AKJ; Cox A; Nasim A; Metaxa S; Missouris CG
    Clin Toxicol (Phila); 2021 Mar; 59(3):208-214. PubMed ID: 32609550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of donepezil in patients with Alzheimer's disease in assisted living facilities.
    Rosenblatt A; Gao J; Mackell J; Richardson S
    Am J Alzheimers Dis Other Demen; 2010 Sep; 25(6):483-9. PubMed ID: 20558849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.